Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Synthetic Cocoa Compound Is Potent Anti-cancer Agent

By Biotechdaily staff writers
Posted on 23 Jun 2008
Cancer researchers have synthesized a chemical substance normally found in cocoa and demonstrated that it has potent chemotherapeutic potential against certain types of tumor cells.

Cocoa-derived flavanols and procyanidins have been previously reported to exhibit anti-oxidant and anti-tumor properties. More...
In this study, investigators at Georgetown University Medical Center (Washington, DC, USA) studied the cellular growth inhibitory effect of chemically-synthesized procyanidin 3-O-Galloylepicatechin-4b,8-3-O-galloylcatechin (GECGC) on a group of 16 cancer cell and 6 normal cell lines.

They reported in the June 1, 2008, issue of the journal Cell Cycle that four of the tumor cell lines – two colon-cancer lines, a cervical cancer line, and a leukemia line - were sensitive to the compound. The most sensitive lines were those with the shortest doubling time. None of the other cancer lines and none of the six normal cell lines were damaged by GECGC.

"This chemical seems to be safe, which makes sense because it has a structure similar to a natural product in cocoa beans - the same beans that are used to make chocolate,” said first author Dr. Min Kim, an oncology researcher at the Georgetown University Medical Center. "We have all heard that eating chocolate is good for you; this study suggests one reason why that might be true. While this work is indeed promising, we have much more study to do before we can say with authority that GECGC has anticancer properties.”


Related Links:
Georgetown University Medical Center

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.